Researchers at the University of Pittsburgh Cancer Institute have identified eight genes that can predict a patient's response to melanoma treatment. The study, presented at the ASCO annual meeting, used Neural Network Analysis to survey over 25,000 genes and regulators in tumor tissues from 21 patients with metastatic melanoma.
A new study found that combining erlotinib and bevacizumab delays disease progression in advanced non-small cell lung cancer patients by 29% compared to those receiving bevacizumab alone. The combination also prolongs median progression-free survival from 3.7 months to 4.8 months.
Researchers identified microRNAs that can predict transplant rejection with high accuracy. Additionally, a new gene-based urine test has been developed to diagnose common kidney transplant complications. The study also explores increasing transplantation through donor chains and transplanting single kidneys from pediatric donors.
Patients with both obesity and diabetes face a significantly worse prognosis, with effective treatment being
Researchers say that improved treatment selection and new therapies could help reduce mortality and rehospitalization rates in acute heart failure. Current treatments have not changed much despite the growing prevalence of heart failure, and the current guidelines emphasize urgent therapy.
The Réseau Respecti-coeur program emphasizes personalized nutrition, allowing patients to adapt their healthy eating habits to their taste and lifestyle. Interactive cooking demonstrations and recipes provide support for heart-healthy meal preparation.
The study found that those who received the vaccine had a significant response rate of 22.1% and progression-free survival of 2.9 months compared to 9.7% and 1.6 months respectively in those that did not. The median overall survival for those receiving vaccine trended positive at 17.6 months.
Acute exacerbations of heart failure are frequent and serious, but recognizing early warning signs can minimize delays in treatment. Shortness of breath is the most common symptom, often described as suffocation or heavy breathing. Families should also be taught to recognize other symptoms such as cough, chest pain, and fatigue.
Researchers at Duke University Medical Center found that nearly half of people age 65 and older have hearing loss, while one-third have vocal problems. The study suggests a causal relationship between the two disabilities, which can increase depression scores and social isolation.
Researchers found that adding gefinitib to standard chemotherapy improved tolerability in advanced head and neck cancer patients, but did not increase survival rates. The combination therapy showed potential in delaying the spread of the disease.
A study by the Medical College of Wisconsin found that young female professional dancers face similar health risks as female athletes due to inadequate nutrition and menstrual irregularities. The researchers studied 22 ballerinas and found that 36% had disordered eating habits, 27% were amenorrheic, and 23% had low bone density.
Studies found promising results for new treatments, including an inotropic drug and vasodilator relaxin, which improved symptoms and outcomes in patients with stable heart failure. Additional research is needed to assess safety and effectiveness of these treatments.
A Phase III trial found that vandetanib significantly improved progression-free survival compared to chemotherapy alone. The therapy, which targets both EGFR and VEGFR, also showed reduced side effects, particularly nausea and vomiting.
A study by Indiana University researchers found that the ingestion of caffeine within an hour of exercise can reduce the symptoms of exercise-induced asthma (EIA). Smaller amounts of caffeine also reduced wheezing, coughing and other symptoms of EIA. The study extended earlier research on caffeine's effectiveness in reducing EIA symptoms.
Several novel biomarkers have been discovered in heart failure syndrome, including ST2, troponins, AGEs, adrenomedullin, and estradiol. These biomarkers offer valuable information for diagnosis, risk stratification, and treatment monitoring, as well as providing insights into the disease's underlying pathophysiology.
New telemonitoring systems provide a more interactive experience for patients with heart failure, offering education, feedback, and advice on adjusting therapy. These systems have shown promise in reducing mortality and hospitalization rates, but service integration is crucial to fully realizing their benefits.
A new study by Memorial Sloan Kettering Cancer Center found that most patients with stage IV colorectal cancer do not require surgery to remove the primary tumor. Chemotherapy is an effective treatment option for these patients, allowing them to avoid surgical complications and start treatment sooner. The retrospective study analyzed 2...